Department of Internal Medicine, Cayuga Medical Center, Ithaca, NY 14850, USA.
Department of Internal Medicine, Cayuga Medical Center, Ithaca, NY 14850, USA.
Am J Emerg Med. 2023 Jun;68:124-126. doi: 10.1016/j.ajem.2023.03.031. Epub 2023 Mar 23.
Post COVID-19 disease pulmonary complications are generally expected among the hospitalized or elderly patients with multiple comorbidities given the gravity of the disease among such patients. However, non-hospitalized patients with less severe symptoms from COVID-19 disease have also been experiencing significant morbidity and difficulty functioning their activities of daily living. Therefore, we aim to characterize post COVID-19 pulmonary complications (symptomatology, clinical and radiological findings) in patients who did not require hospitalization but had significant outpatient visits secondary to COVID-19 sequelae.
This is a two part cross-sectional study based on a retrospective chart review. Patients with COVID-19 disease not requiring hospitalization but followed up at pulmonology clinic with respiratory symptoms were analyzed twice in an interval of 12 months. 23 patients in first cross-section group (followed up from December 2019 to June 2021) and 53 patients in second group (followed up from June 2021 to July 2022) were included in the analyses. Differences in mean and percentage of baseline characteristics and clinical outcomes between the two groups are analyzed using unpaired t-tests and Chi-squared tests respectively. Post COVID-19 disease symptoms are classified in to 3 different groups (mild, moderate and severe) based on duration of symptoms and presence or absence of hypoxia.
Dyspnea on exertion (DOE) was the common compliant in majority of patients in both cross-section groups (43.5% vs 56.6%). Mean age in years were 33 and 50 in first and second cross-section groups respectively. Majority of the patients had mild and moderate symptoms in both groups (43.5% vs 9.4%, P = 0.0007; 43.5% vs 83%, P = 0.005). Mean duration of symptoms in first cross-section group was 3.8 whereas 10.5 months (P = 0.0001) in second cross-section group.
Our study outlines the burden of post COVID-19 disease pulmonary complications in patient group where these complications are less expected. Strategies for the implementation of multidisciplinary post COVID-19 care clinic along with mass vaccination awareness campaigns in rural US should be prioritized to mitigate this existing burden.
鉴于 COVID-19 患者的病情严重,住院或患有多种合并症的老年患者通常会出现 COVID-19 后肺部并发症。然而,患有 COVID-19 疾病且症状较轻、未住院的非住院患者也经历了显著的发病率和日常生活活动能力障碍。因此,我们旨在描述 COVID-19 后肺部并发症(症状、临床和影像学发现)在因 COVID-19 后遗症而需要大量门诊就诊但无需住院的患者中的特征。
这是一项基于回顾性图表审查的两部分横断面研究。对无需住院但因 COVID-19 疾病在呼吸科门诊接受治疗的呼吸道症状患者进行了两次分析,两次分析之间的时间间隔为 12 个月。第一交叉组(2019 年 12 月至 2021 年 6 月随访)有 23 例患者,第二组(2021 年 6 月至 2022 年 7 月随访)有 53 例患者。使用配对 t 检验和卡方检验分别分析两组之间基线特征和临床结局的平均值和百分比差异。根据症状持续时间和是否存在低氧血症,将 COVID-19 疾病后症状分为 3 个不同组(轻度、中度和重度)。
两组交叉组中,大多数患者(43.5% vs. 56.6%)的主要抱怨是运动时呼吸困难(DOE)。第一和第二交叉组的平均年龄分别为 33 岁和 50 岁。两组中大多数患者为轻度和中度症状(43.5% vs. 9.4%,P=0.0007;43.5% vs. 83%,P=0.005)。第一交叉组症状的平均持续时间为 3.8 个月,而第二交叉组为 10.5 个月(P=0.0001)。
我们的研究概述了在这些并发症不太可能出现的患者群体中 COVID-19 后肺部并发症的负担。应优先制定多学科 COVID-19 后护理诊所的实施策略,并在农村美国开展大规模疫苗接种意识运动,以减轻这一现有负担。